Hyperglycemia, polyuria, polydipsia, polyphagia, and renal glycosuria are all symptoms of diabetes mellitus (DM), also known as diabetes. Diabetic ketoacidosis, hyperosmolar hyperglycemia, there is a possibility that the illness could result in a number of different complications, some of which include cardiovascular disease, chronic renal disease, stroke, foot ulcers, visual damage, nerve damage, and cognitive impairment. The principal objective of this research was to regulate whether or not a methanolic extract of Cyperus articulates (MECA) rhizome possessed an antidiabetic effect. In order to evaluate the effectiveness of MECA as an antidiabetic agent, streptozotocin-induced diabetic rats were used in an experiment involving thiobarbituric acid reactive substances. In the aforementioned experiments, it was discovered that in streptozotocin (STZ) induced diabetic rats, MECA at doses of 200 and 400 mg/kg reduced blood glucose levels from ‘254.41 ± 11.7 to 98.50 ± 2.5 and 283.83 ± 27.8 to 96.35 ± 3 mg/dl respectively, while glibenclamide-treated rats had a decrease in blood glucose from 291.12 ± 17.1to 91.50 ± 1.7 mg. This decrease was statistically significant (p < 0.05) when compared to the healthy control group. The effects of MECA on TBARS, GSH, and catalase in experimentally diabetic rats were found to be more pronounced than in the saline control group, and a greater rise in lipid peroxidation in the liver and kidney was seen in the diabetic group than in the saline group. Liver and kidney TBARS levels were observed to be considerably (p < 0.05, p < 0.001) reduced after MECA treatment, as were GSH levels in the STZ-control group and catalase activities in the experimental rats